Full Press Release Details
CGuard Embolic Prevention System to be Prominently Featured in Live Case Transmissions at LINC, 22nd to the
25th January 2019, in Leipzig, Germany
Clinical Presentations, Updates, and Panel Discussions on CGuard EPS to also be presented
Aviv, Israel- January 18, 2019 - InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) /
thrombus management technologies and neurovascular devices, today announced that its CGuard Carotid Embolic Prevention
System (EPS) will be featured in two live case transmissions at the Leipzig Interventional Course (LINC) 2019 to be held from
January 22nd to the 25th at the Trade Fair Leipzig, Hall 2 in Leipzig, Germany. CGuard EPS will also be featured in two
panel discussions at the conference.
10:57 - 11:22 Live from Bergamo Technical Forum Room 3
21 - BG 02: male, 64 years (D-V)
left carotid artery disease in a patient with coronary artery disease
F. Castriota, A. Micari
16:30 - 18:00 Live from Leipzig Technical Forum Room 3
27 - LEI 09: female, 56 years (L-K)
of the left common carotid artery after TEA
A. Schmidt, S. Br unlich
presentations featuring CGuard EPS will include:
| What: | Initial clinical study of the new CGuard MicroNet covered carotid-stent: One size fits all - experimental data and clinical results C. Wissgott, MD, Germany |
| When: | January 22, 10:27 - 10:33 AM Central European Time |
| Where: | Room 3 - Technical Forum |
| What: | PARADIGM-EXTEND prospective academic trial of CGuard MicroNet covered self-expandable stent system: Cumulative 3-year clinical and duplex ultrasound evidence for safety, efficacy and durability of stroke prevention Professor P. Musialek, Poland |
| When: | January 22, 15:05 - 15:10 PM Central European Time |
| Where: | Room 7 - Speaker's Room |
| What: | Intermediate results of a prospective randomized study in carotid artery revascularisation: the Acculink stent vs. the mesh covered stent (CGuard ) P. Ignatenko, MD, Russia |
| When: | January 22, 15:15 - 15:20 PM Central European Time |
| Where: | Room 7 - Speaker's Room |
| What: | Interim results from a prospective real-world multicentre clinical practice of CAS using the CGuard embolic prevention system: the IRONGUARD 2 study W. Mansour, MD, Italy |
| When: | January 22, 15:20 - 15:25 PM Central European Time |
| Where: | Room 7 - Speaker's Room |
| What: | Comparative analysis of carotid artery stenting and carotid endarterectomy in clinical practice Professor Andrey Karpenko, Russia |
| When: | January 22, 15:30 - 15:35 PM Central European Time |
| Where: | Room 7 - Speaker's Room |
CGuard Carotid Embolic Prevention System will also be featured at the Company's booth (18c2). InspireMD will be represented
by its management, sales and clinical staff and welcomes all enquiries from clinicians and other interested parties.
is a leading global forum for new methods in the field of vascular medicine. LINC brings together medical professionals from different
specialties around the world who perform endovascular interventions.
seeks to utilize its proprietary MicroNet technology to make its products the industry standard for embolic protection
and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization,
no reflow and major adverse cardiac events.
intends to pursue applications of this MicroNet technology in coronary, carotid (CGuard ), neurovascular, and peripheral
artery procedures. InspireMD's common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants
are quoted on the NYSE American under the ticker symbol NSPR.WS.
Chief Financial Officer
Phone: 1-888-776-6804 FREE
Email: craigs@inspiremd.com